Literature DB >> 3274828

Prolongation of murine cardiac allograft survival by the anti-interleukin-2 receptor monoclonal antibody AMT-13.

R L Kirkman1, L V Barrett, W A Koltun, T Diamantstein.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3274828

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  3 in total

Review 1.  Daclizumab: a review of its use in the prevention of acute rejection in renal transplant recipients.

Authors:  L R Wiseman; D Faulds
Journal:  Drugs       Date:  1999-12       Impact factor: 9.546

2.  Anti-IL-2 receptor monoclonal antibody AMT-13 increases soluble IL-2 receptor levels in vivo.

Authors:  K Burkhardt; T E Mandel; T Diamantstein; M S Loughnan
Journal:  Immunology       Date:  1989-02       Impact factor: 7.397

3.  Cardiac allograft survival in mice treated with IL-2-PE40.

Authors:  H Lorberboum-Galski; L V Barrett; R L Kirkman; M Ogata; M C Willingham; D J FitzGerald; I Pastan
Journal:  Proc Natl Acad Sci U S A       Date:  1989-02       Impact factor: 12.779
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.